News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Jerónimo Rafael Rodríguez Cid: EGFR mutated patients doesnt have any benefit with immunotherapy in TKI’s resistant tumors
Photo of Jerónimo Rafael Rodríguez Cid taken from medicasur.com.mx
Sep 6, 2024, 15:44

Jerónimo Rafael Rodríguez Cid: EGFR mutated patients doesnt have any benefit with immunotherapy in TKI’s resistant tumors

Jerónimo Rafael Rodríguez Cid, Medical Oncologist in CDMX, shared a post on X:

“We published in JCO by ASCO the analysis of this trial which reflects that EGFR mutated (lung cancer) patients doesn’t have any benefit of treatment with immunotherapy in TKI’s resistant tumors.

We will never stop trying.”

Jerónimo Rafael Rodríguez Cid: EGFR mutated patients doesnt have any benefit with immunotherapy in TKI's resistant tumors

Source: Jerónimo Rafael Rodríguez Cid/X

 

ASCO JCO cancer EGFR immunotherapy Jerónimo Rafael Rodríguez Cid Lung cancer OncoDaily Oncology TKI
Special Coverage
Blog
Dec 22, 2024, 05:05
Ruben Mesa: Excited to visit Atrium Health Levine Cancer Pineville
Blog
Dec 22, 2024, 05:02
Muhammad Umair Mushtaq: Are Stem Cell Transplants Safe for Myelofibrosis Patients Over 70?
Blog
Dec 22, 2024, 05:00
Elvina Almuradova: Being a part of Giuseppe Curigliano's team is an invaluable scientific milestone for me
Blog
Dec 22, 2024, 04:58
Summary slide for PFS in selected trials by IGHV status caveat for CLL by Nitin Jain
Insight
Dec 22, 2024, 04:53
Cancer survivors are growing in number - National Cancer Institute
Blog
Dec 22, 2024, 04:52
Registration is open for the ESMO Gastrointestinal Cancers Congress 2025
Blog
Dec 22, 2024, 04:49
Amalya Sargsyan: New ESO Rare Cancer Series podcast with Salvatore Provenzano
Insight
Dec 22, 2024, 04:47
Journal of Psychosocial Oncology Research and Practice: Vol. 6, Number 4 - IPOS
Science
Dec 22, 2024, 04:40
The prevalence of widespread guideline-discordant LDCT screening in a low-risk population by So Yeon Kim et al.
Blog
Dec 22, 2024, 04:38
The new Institute of Cancer Research spinout company Sentinal4D has been announced to the public
Blog
Dec 22, 2024, 04:34
Nermean Mostafa: Honored to co-organize women cancer patient advocacy session hosted by 8th Gyne-Oncology conference
Blog
Dec 22, 2024, 04:24
Jordan Rathkopf: As 2024 winds down, we’ve been reflecting on what a year it’s been